Target intelligence / Profile preview

ATP-dependent RNA helicase DDX18 (DDX18)

Target
DDX18
Molecular classification
Enzyme, DEAD-box RNA helicase, DEAD box polypeptides (DDX) family
01

Overview

ATP-dependent RNA helicase DDX18 is a member of the DEAD-box protein family, characterized by the conserved Asp-Glu-Ala-Asp (DEAD) motif. DDX18 functions primarily as an RNA helicase, unwinding RNA secondary structures in an ATP-dependent manner and playing a crucial role in diverse RNA metabolic processes such as translation initiation, splicing, and ribosome and spliceosome assembly. It is essential for the regulation of ribosome biogenesis and cell proliferation and is activated by the Myc protein. DDX18 is necessary for embryonic stem cell pluripotency, acting to preserve rDNA chromatin structure and prevent repressive chromatin modifications. Loss of DDX18 function can induce p53-dependent G1 cell cycle arrest and apoptosis, highlighting its role in cell survival and hematopoiesis. Overexpression and dysfunction of DDX18 have been implicated in several cancer types, where it serves as a key downstream effector of oncogenic signaling pathways and promotes aggressive tumor behavior. DDX18 also plays a role in viral infection, such as promoting replication of porcine reproductive and respiratory syndrome virus (PRRSV) by interacting with viral nonstructural proteins and facilitating viral propagation. Current evidence does not list approved or investigational drugs directly targeting DDX18, nor detailed mechanisms of action or safety data for DDX18 inhibitors. DDX18’s identification as a hub gene and overexpression in cancers suggest potential as a biomarker or therapeutic target, but clinical translation remains to be established.

Other names
Has1MRDBDEAD box protein 18DEAD (Asp-Glu-Ala-Asp) box polypeptide 18Myc-regulated DEAD box proteinHelicase Associated with Set1 homolog (S. cerevisiae)
02

Biological functions

Regulation of RNA metabolismRibosome biogenesisCell proliferationTranslation initiationRNA splicing (nuclear and mitochondrial)R-loop homeostasisChromatin structure maintenanceCell cycle regulationPluripotency maintenance in embryonic stem cells
03

Disease associations

CancerHematopoietic cell developmental disordersEndocrine-resistant breast cancerViral infectionsBloom syndrome
04

Safety considerations

Potential oncogenic risk if upregulatedtargeting may impact essential RNA processing and cell viability
05

Biomarkers

Overexpression in several cancers (e.g., triple-negative breast cancer, colorectal cancer, esophageal squamous cell carcinoma, gastric cancer)hub gene in oncogenic cell proliferation

Beyond the preview

Go deeper on ATP-dependent RNA helicase DDX18 (DDX18).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP-dependent RNA helicase DDX18 (DDX18).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call